SDH complex dehydrogenates succinate

Stable Identifier
R-HSA-70994
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Synonyms
Succinate + Q10 => Fumarate + Q10H2
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The succinate dehydrogenase complex (SDH, complex II), associated with the inner mitochondrial membrane, catalyzes the dehydrogenation of succinate to fumarate, reducing ubiquinone (Q10) to ubiquinol (Q10H2) on the membrane part of the enzyme. FAD is covalently bound to His-99 of the SDHA subunit (PDB 6VAX; Sharma et al., 2020). The redox potential of Q10H2 is then used in the electron transfer chain to drive a proton motive force to generate ATP (Devertanian et al., 1964; Renkema et al., 2015)

The endogenous metabolite itaconate has been shown to bind and inhibit Complex II, leading to an accumulation of succinate. Elevated succinate levels modulate immune, hypoxic and metabolic reprogramming pathways, including during oncogenesis (Booth et al, 1952; Selak et al., 2005; Cordes et al., 2016; reviewed by Hayash et al., 2018; Peace & O'Neill, 2022). The mitochondrial heat shock protein 75 kDa (TRAP1) inhibits Complex II which elicits respiratory downregulation, leading to a pseudohypoxic state. This state is caused by succinate-dependent HIF1-alpha stabilisation which, in turn, can promote tumorigenesis (Sciacovelli et al. 2013, Yoshida et al. 2013, Guzzo et al. 2014).

Mutations in all four SDH subunits (SDHA, SDHB, SDHC, SDHD) have been reported, leading to distinct phenotypes of SDH deficiency and tumors (reviewed by Briere et al., 2005).
Literature References
PubMed ID Title Journal Year
14946179 The inhibitory effects of itaconic acid in vitro and in vivo

DEEDS, F, BOOTH, AN, WILSON, RH, Taylor, J

J Biol Chem 1952
23564345 Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis

Lee, MJ, Miyajima, N, Picard, D, Trepel, J, Tsutsumi, S, Tatokoro, M, Hasumi, H, Koga, F, Muhlebach, G, Kihara, K, Beebe, K, Yoshida, S, Nakamura, K, Sourbier, C, Neckers, L, Fukushima, H, Chen, Y, Lee, S, Mohney, RP, Xu, W, Vartholomaiou, E

Proc. Natl. Acad. Sci. U.S.A. 2013
15652751 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

MacKenzie, ED, Boulahbel, H, Selak, MA, Pan, Y, Armour, SM, Watson, DG, Gottlieb, E, Mansfield, KD, Simon, MC, Thompson, CB

Cancer Cell 2005
25564869 Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells

Rasola, A, Bernardi, P, Guzzo, G, Sciacovelli, M

Oncotarget 2014
27374498 Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation

Jones, RG, Sergushichev, A, Khader, S, Lampropoulou, V, Pearce, EJ, Cervantes-Barragan, L, Diamond, MS, Ma, X, Loginicheva, E, Bambouskova, M, Griss, T, Artyomov, MN, Vincent, EE, Diwan, A, Randolph, GJ, Weinheimer, CJ, Nair, S, Huang, SC

Cell Metab 2016
15987702 Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations

Wortham, NC, Griffiths, JR, Moat, SJ, Pollard, PJ, Barclay, E, Barwell, J, Mitchell, M, Tomlinson, IP, Alam, NA, Hargreaves, IP, Poulsom, R, Dalgleish, A, Heales, SJ, Hodgson, SV, Hunt, T, Gleeson, MJ, McGrath, JA, Brière, JJ, Rustin, P, Chung, YL, Olpin, S

Hum Mol Genet 2005
17182618 Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF

Myllyharju, J, Remes, AM, Hirsilä, M, Hassinen, IE, Kivirikko, KI, Koivunen, P

J Biol Chem 2007
14249115 STUDIES ON SUCCINATE DEHYDROGENASE. I. SPECTRAL PROPERTIES OF THE PURIFIED ENZYME AND FORMATION OF ENZYME-COMPETITIVE INHIBITOR COMPLEXES

DERVARTANIAN, DV, VEEGER, C

Biochim Biophys Acta 1964
27189937 Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels

Metallo, CM, Wallace, M, Cordes, T, Murphy, AN, Koseki, H, Divakaruni, AS, Michelucci, A, Sapcariu, SC, Cabrales, P, Hiller, K, Sousa, C

J Biol Chem 2016
30844107 Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1α in cancer

Harada, H, Yokota, A, Hayashi, Y, Huang, G

Cancer Sci 2019
23747254 The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase

Defilippi, P, Nannini, N, Calabrese, F, Rasola, A, Laudiero, G, Bernardi, P, Guzzo, G, Frezza, C, Zheng, L, Esposito, F, Landriscina, M, Morello, V, Sciacovelli, M

Cell Metab. 2013
16143825 Succinate dehydrogenase deficiency in human

Djouadi, F, Gimenez, AP, El Ghouzzi, V, Favier, J, Briere, JJ, Rustin, P, Benit, P

Cell Mol Life Sci 2005
Participants
Participates
Catalyst Activity

succinate dehydrogenase (ubiquinone) activity of SDH complex [mitochondrial inner membrane]

This event is regulated
Orthologous Events
Cross References
RHEA
Reviewed
Cite Us!